ReposiTrak Management
Management criteria checks 4/4
ReposiTrak's CEO is Randy Fields, appointed in Jan 1990, has a tenure of 36.5 years. total yearly compensation is $1.85M, comprised of 60.3% salary and 39.7% bonuses, including company stock and options. directly owns 21.56% of the company’s shares, worth $34.91M. The average tenure of the management team and the board of directors is 16.4 years and 13.4 years respectively.
Key information
Randy Fields
Chief executive officer
US$1.9m
Total compensation
| CEO salary percentage | 60.33% |
| CEO tenure | 36.5yrs |
| CEO ownership | 21.6% |
| Management average tenure | 16.4yrs |
| Board average tenure | 13.4yrs |
Recent management updates
Recent updates
Narrative Update • Jun 24
TRAK: Expanding Food Traceability Adoption Will Support Future Upside Potential
Analysts kept their fair value estimate for ReposiTrak steady at $16.00, with only minor adjustments to inputs such as the discount rate and future P/E. These changes fine tune their price target view rather than reshape it.Seeking Alpha • Jun 20
ReposiTrak: Walmart And Kroger May Prove The Bears Wrong
Summary ReposiTrak earns a buy rating, targeting $10.2/share by FY 2027, implying 11% upside after a sharp recent pullback. TRAK’s fundamentals remain solid, with profitability and operating leverage improving despite flat Q3 revenue due to FSMA compliance deadline timing shifts. Demand for TRAK’s traceability solutions appears robust, supported by retailer adoption and industry trends beyond regulatory requirements. Risks include slower-than-expected traceability adoption, but TRAK’s scalable SaaS model and regulatory tailwinds underpin an attractive risk-reward profile. Read the full article on Seeking AlphaNarrative Update • Jun 03
TRAK: Expanding Traceability And Compliance Adoption Will Support Future Upside Potential
Analysts have adjusted their price target on ReposiTrak to $16.00. The update reflects refreshed assumptions around revenue growth, profit margins, the discount rate and a slightly lower future P/E multiple.Narrative Update • May 05
TRAK: Expanding Food Traceability Adoption And Compliance Wins Will Drive Upside
Analysts have kept their ReposiTrak price target effectively unchanged at approximately $16.00, reflecting only very small tweaks in inputs such as discount rate, revenue growth, profit margin and future P/E assumptions, rather than any shift in their overall view of the stock. What's in the News A wholesale grocery cooperative in the Southern United States became the first wholesaler to reach full supplier to store traceability using ReposiTrak’s Touchless Traceability solution, achieving FSMA 204 compliance without case-level scanning or changes to distribution center workflows (Key Developments).Narrative Update • Apr 19
TRAK: Expanding Traceability Network Adoption Will Support Future Upside
Analysts held ReposiTrak's fair value estimate at $16.00 per share while making only very small tweaks to assumptions such as the discount rate and future P/E, reflecting largely unchanged views on the stock's risk and earnings profile. What's in the News ReposiTrak reported that eighteen fresh fruit and vegetable companies have joined the queue for the ReposiTrak Traceability Network to prepare for FDA Key Data Element sharing across their supply chains, covering a wide range of growers and distributors across the United States (Key Developments).Narrative Update • Apr 04
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have maintained their $16.00 price target on ReposiTrak, linking this steady view to only slight adjustments in discount rate and future P/E assumptions rather than any change in projected growth or profitability. What's in the News ReposiTrak and SPAR Group, Inc.Narrative Update • Mar 21
TRAK: Expanding Traceability Adoption And Share Repurchases Will Support Future Upside
Analysts have reaffirmed a $16.00 price target for ReposiTrak, citing only minimal tweaks to underlying assumptions such as discount rate, revenue growth, profit margin and future P/E, which together leave their overall valuation view effectively unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability is reported as the first to achieve end to end traceability under FDA FSMA Section 204, with hundreds of thousands of Key Data Element records generated across shipments, and several more corporate customers nearing similar go live milestones (Key Developments).Narrative Update • Mar 06
TRAK: Expanding Traceability Network And Share Buybacks Will Support Future Upside
Analysts have modestly reduced their price target on ReposiTrak to reflect a slightly lower future P/E assumption of 36.44x, while keeping key fair value and growth inputs broadly unchanged. What's in the News A grocery retailer using ReposiTrak Touchless Traceability has achieved end to end FSMA 204 traceability, generating hundreds of thousands of FDA Key Data Element records without case level scanning, with three more corporate customers close to similar go live points (Key Developments).Narrative Update • Feb 19
TRAK: Traceability Network Adoption Will Support Higher Future Profitability
Analysts have reduced their price target on ReposiTrak from $29 to $16, citing updated assumptions in their models for slower revenue growth, a lower future P/E multiple, and a higher profit margin profile. What's in the News ReposiTrak reported completing a share repurchase program announced on May 9, 2019, buying back a total of 2,220,026 shares, or 11.63% of the company, for US$14.46 million, including 79,927 shares, or 0.44%, repurchased between October 1, 2025 and December 31, 2025 for US$1.1 million (Key Developments).Analysis Article • Oct 01
Investors Will Want ReposiTrak's (NYSE:TRAK) Growth In ROCE To Persist
There are a few key trends to look for if we want to identify the next multi-bagger. One common approach is to try and...Analysis Article • Aug 02
Subdued Growth No Barrier To ReposiTrak, Inc.'s (NYSE:TRAK) Price
ReposiTrak, Inc.'s ( NYSE:TRAK ) price-to-earnings (or "P/E") ratio of 46.4x might make it look like a strong sell...Analysis Article • May 27
ReposiTrak's (NYSE:TRAK) Performance Is Even Better Than Its Earnings Suggest
ReposiTrak, Inc. ( NYSE:TRAK ) just reported healthy earnings but the stock price didn't move much. Investors are...Analysis Article • Apr 12
Earnings Not Telling The Story For ReposiTrak, Inc. (NYSE:TRAK)
With a price-to-earnings (or "P/E") ratio of 62.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...Analysis Article • Nov 09
ReposiTrak, Inc. (NYSE:TRAK) Not Lagging Market On Growth Or Pricing
With a price-to-earnings (or "P/E") ratio of 71.3x ReposiTrak, Inc. ( NYSE:TRAK ) may be sending very bearish signals...
New Narrative • Oct 07
Critical Focus On Traceability Solutions Powers Revenue Growth And Profitability Surge
Emphasis on enhancing traceability solutions and strategic revenue focus predicts significant growth, with aims to improve net margins and year-over-year growth.Seeking Alpha • Oct 06
Track And Trace, But Don't Race: Why ReposiTrak Might Be Overvalued
Summary ReposiTrak shows solid growth potential with traceability services and recurring revenue but is currently overvalued with a high P/E ratio of 62.09x. Despite strong financials and profitability, rising operational expenses and heavy FDA dependency pose significant risks. Expansion into adjacent markets and AI-driven operational efficiencies are promising, but traceability revenue remains a small portion of the business. Given the speculative nature and high valuation, I recommend holding off on investing in ReposiTrak at this price. Read the full article on Seeking AlphaAnalysis Article • Jul 24
ReposiTrak, Inc.'s (NYSE:TRAK) P/E Is Still On The Mark Following 28% Share Price Bounce
ReposiTrak, Inc. ( NYSE:TRAK ) shareholders have had their patience rewarded with a 28% share price jump in the last...Analysis Article • Mar 23
ReposiTrak (NYSE:TRAK) Has More To Do To Multiply In Value Going Forward
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Analysis Article • Feb 28
Why Investors Shouldn't Be Surprised By ReposiTrak, Inc.'s (NYSE:TRAK) 28% Share Price Surge
Despite an already strong run, ReposiTrak, Inc. ( NYSE:TRAK ) shares have been powering on, with a gain of 28% in the...CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$7m |
| Dec 31 2025 | n/a | n/a | US$7m |
| Sep 30 2025 | n/a | n/a | US$7m |
| Jun 30 2025 | US$2m | US$1m | US$7m |
| Mar 31 2025 | n/a | n/a | US$6m |
| Dec 31 2024 | n/a | n/a | US$6m |
| Sep 30 2024 | n/a | n/a | US$6m |
| Jun 30 2024 | US$2m | US$1m | US$5m |
| Mar 31 2024 | n/a | n/a | US$5m |
| Dec 31 2023 | n/a | n/a | US$5m |
| Sep 30 2023 | n/a | n/a | US$5m |
| Jun 30 2023 | US$2m | US$1m | US$5m |
| Mar 31 2023 | n/a | n/a | US$5m |
| Dec 31 2022 | n/a | n/a | US$4m |
| Sep 30 2022 | n/a | n/a | US$4m |
| Jun 30 2022 | US$2m | US$1m | US$3m |
| Mar 31 2022 | n/a | n/a | US$3m |
| Dec 31 2021 | n/a | n/a | US$3m |
| Sep 30 2021 | n/a | n/a | US$4m |
| Jun 30 2021 | US$2m | US$1m | US$4m |
| Mar 31 2021 | n/a | n/a | US$3m |
| Dec 31 2020 | n/a | n/a | US$2m |
| Sep 30 2020 | n/a | n/a | US$1m |
| Jun 30 2020 | US$2m | US$1m | US$1m |
Compensation vs Market: Randy's total compensation ($USD1.85M) is about average for companies of similar size in the US market ($USD1.61M).
Compensation vs Earnings: Randy's compensation has been consistent with company performance over the past year.
CEO
Randy Fields (79 yo)
36.5yrs
Tenure
US$1,853,310
Compensation
Mr. Randall K. Fields, also known as Randy, co-founded Park City Group, Inc. (Formerly, Fields Software Group) in 1990 and has been its Chairman, Chief Executive Officer and President since June 2001. He s...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 36.5yrs | US$1.85m | 21.56% $ 34.9m | |
| Chief Financial Officer | 7.2yrs | US$460.70k | 0.33% $ 539.2k | |
| General Counsel & Corporate Secretary | 24.3yrs | US$225.00k | 0.34% $ 545.0k | |
| Chief Technology Officer | no data | no data | no data | |
| Chief Customer Officer | 8.5yrs | no data | no data | |
| Senior Vice President of Sales | no data | no data | no data | |
| Vice President of Development | no data | US$147.00k | no data | |
| Investor Relations Professional | no data | no data | no data |
16.4yrs
Average Tenure
70yo
Average Age
Experienced Management: TRAK's management team is seasoned and experienced (16.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 25.1yrs | US$1.85m | 21.56% $ 34.9m | |
| Independent Director | 13.4yrs | US$75.00k | 3.09% $ 5.0m | |
| Director | less than a year | US$8.33k | no data | |
| Independent Director | 18.8yrs | US$75.00k | 4.34% $ 7.0m | |
| Independent Director | 6.9yrs | US$75.00k | 0.30% $ 486.8k |
13.4yrs
Average Tenure
78yo
Average Age
Experienced Board: TRAK's board of directors are seasoned and experienced ( 13.4 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/07/12 06:13 |
| End of Day Share Price | 2026/07/10 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
ReposiTrak, Inc. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Forte | D.A. Davidson & Co. |
| Ananda Baruah | Loop Capital Markets |
| Thomas Forte | Maxim Group |